Total Funding
23
44
Total FundingVenture - Series Unknown raised
Growth Score 23 in past quarter
-2 pts
Heat Score 44 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
66464
AccuVein develops products that aid in the visualization of peripheral vasculature.
- James D. Lackie: Director
- Chuck Johnson: CFOPast Role: Spinifex Pharmaceuticals, Chief Financial Officer
About the Company
AccuVein specializes in vein visualization technology. Its flagship product, the AV400, is a hand-held, non-contact vein illumination solution. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology as embodied in its growing
patent portfolio that covers a broad range of imaging and medical diagnostic technologies.
The company was founded in 2006 and is headquartered in Medford, New York.

